Variant position: 380 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 416 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human RALPAETHVVVAAQPTRNFS VWIGGSILASLRAFQSCWVLR
Mouse HSLSPEDHVVVMAHPNRNLS VWIGGSILASLHAFQSCWVLR
Rat RRLGPEAHVVVVAQANRNLS VWIGGSILASLCAFQTRWVLR
Bovine RNLPPEAHVVVMAQPTRNFS VWIGGSILASLRTFQSCWVLR
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 416 Actin-like protein 9
Homozygous pathogenic variants in ACTL9 cause fertilization failure and male infertility in humans and mice.
Dai J.; Zhang T.; Guo J.; Zhou Q.; Gu Y.; Zhang J.; Hu L.; Zong Y.; Song J.; Zhang S.; Dai C.; Gong F.; Lu G.; Zheng W.; Lin G.;
Am. J. Hum. Genet. 108:469-481(2021)
Cited for: INVOLVEMENT IN SPGF53; VARIANTS SPGF53 LEU-345; LEU-380 AND 403-TYR--TYR-416 DEL; CHARACTERIZATION OF VARIANTS SPGF53 LEU-345; LEU-380 AND 403-TYR--TYR-416 DEL; TISSUE SPECIFICITY; SUBCELLULAR LOCATION; INTERACTION WITH ACTL7A; FUNCTION;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.